Experts comment on Senate bill that replaces monopolies for medicines with system of prizes
Written by James Love Continue Reading
Search Results for: car t
The Big Idea: Prizes to Stimulate R&D for New Medicines
Chicago-Kent Law Review
Volume 82, Number 3
2007
Previously KEI Research Paper 2007:1, Revised 26 March 2007. Originally the Ruby Hutchison
Memorial Address, Presented November 14, 2006
James Love, Knowledge Ecology International
Tim Hubbard, Wellcome Trust Sanger Institute
The paper is available in PDF format here: http://studentorgs.kentlaw.iit.edu/cklawreview/issues/vol-82-no-3/
KEI Comments to EWG 2nd Web-based Public Hearing: Defending the Status Quo, or Roadmap for Change?
On Saturday, KEI filed comments with the WHO EWG’s 2nd web based hearing. Our comments focused on the criteria for new proposals. Continue Reading
Scholarly and Technical Articles and Books on Innovation Prizes
This paper has now been replaced by an updated version here: /prizes/cites
—————
An Annotated Bibliography of Scholarly and Technical Articles and Books on Innovation Prizes
KEI Research Note 2008:2
(Updated October 4, 2010)
2010. William Fisher and Talha Syed. Drugs, Law, and the Health Crisis in the Developing World. Stanford University Press. [link] Continue Reading
Prominent Innovation Prizes And Reward Programs
This has been replaced by 2008:1 Selected Innovation Prizes and Reward Programs.
PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS
KEI Research Note 2007:1
Benjamin Krohmal*
March 1, 2007
Reimbursement Categories of Medicines in European Union Member Countries
Source: EUROMEDSTAT (http://www.euromedstat.cnr.it/reports/reports_reimbursement_categories.asp)
AUSTRIA
"Heilmittelverzeichnis": Pharmaceuticals listed on the "Heilmittelverzeichnis" (Pharmaceutical List) qualify for automatic reimbursement (100%)
Continue Reading
KEI issues report on Selected Innovation Prizes and Reward Programs
Written by James Love
Thursday, 20 March 2008
On March 20, 2008, KEI published "Selected Innovation Prizes and Reward Programs" (cite as KEI Research Note 2008:1). The paper, which is available on the Internet here: https://www.keionline.org/misc-docs/research_notes/kei_rn_2008_1.pdf, provides the most comprehensive account of historical uses of prizes to induce innovation now available. The introduction to the 51 page report follows:
The role of prizes in stimulating R&D
Written by James Love
Saturday, 20 October 2007
KEI Comment to the World Health Organization (WHO) Intergovernmental Working Group (IGWG) on Public Health, Innovation and Intellectual Property Rights
James Love, Knowledge Ecology International
30 September 2007
Introduction
Expert comments on Medical Innovation Prize Fund
Written by James Love
Tuesday, 23 October 2007
The following are comments by experts on innovation and public health, beginning with consumer and public health groups, followed by academic experts and others.
KEI & UNU-MERIT Maastricht Workshop on Medical Innovation Prizes
Written by Administrator
Friday, 18 January 2008
Medical innovation prizes as a mechanism to promote innovation and access
Date: January 28-29, 2008
Location: UNU-MERIT in Maastricht, The Netherlands
Monday morning: Aula, Maastricht University, Faculty of Economics, Tongersestraat 53
Monday afternoon & Tuesday: Aula, Maastricht University, Minderbroedersberg 4-6